Application 021292
- Type
- NDA
- Sponsor
- PROVELL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 002 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 003 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 004 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 005 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 006 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 007 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 008 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 009 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 010 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 011 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 012 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021292-001 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.025MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-002 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.05MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-003 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.075MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-004 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.088MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-005 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.1MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-006 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.112MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-007 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.125MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-008 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.137MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-009 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.15MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-010 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.175MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-011 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.2MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-012 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.3MG | TABLET / ORAL | 2002-05-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021292-001 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-002 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-003 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-004 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-005 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-006 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-007 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-008 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-009 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-010 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-011 | AB2 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-001 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-002 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-003 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-004 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-005 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-006 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-007 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-008 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-009 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-010 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-011 | AB2 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-001 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-002 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-003 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-004 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-005 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-006 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-007 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-008 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-009 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-010 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-011 | AB2 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-001 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-002 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-003 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-004 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-005 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-006 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-007 | AB2 | 1 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | ddec2148-f97e-4a79-9943-4bef2386a7f2 | 2025-01-21 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 7ade3f9e-e3d2-401b-a6b7-aa4c9d1c9861 | 2025-01-20 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Direct_rx | 2b4bbe49-4bd0-ba16-e063-6394a90acefc | 2025-01-09 | Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Direct_Rx | 2b361866-e981-567c-e063-6294a90a5a5c | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 27e98e6d-9fd7-3a94-e063-6394a90a1dcb | 2024-12-24 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 576dcd01-d151-42ac-acd1-480a13bae176 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | 29bb8dbe-f8ba-e2ba-e063-6394a90af38c | 2024-12-20 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | a0ffe111-3574-4481-a732-b68a7d58ef71 | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | a55e735f-a5b0-4b85-9fd7-3a4b6723a81b | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 893f9d10-7ce5-4ae6-8f03-dfde35ca6c30 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | f23cacf6-0509-4e6b-bb59-6f1c17b16411 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 6edb9499-b869-4ec8-82d7-56d267fd3dec | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 2ee67e24-d72f-4419-a7d2-95bb44d9dd26 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | b57d0cc5-9fc7-496a-9bfa-417a288bb825 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 68a6702d-ca0b-4e04-88a6-4accc8fb459e | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | e1f77539-2156-4890-baca-8b13779c745c | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Amneal Pharmaceuticals NY LLC | fca88c97-5cd4-4834-ba87-deb5bd637788 | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 2646a481-09a5-af6a-e063-6394a90a16da | 2024-11-06 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 924bb6e9-4b2b-406f-a0a8-376b1f22f1f5 | 2024-10-14 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCarePharmaceuticals, Inc. | 2380859a-5b65-f88f-e063-6394a90aa4e2 | 2024-10-02 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 70915 | SUPPL | 2022-05-03 |
| 70873 | SUPPL | 2022-05-02 |
| 55504 | SUPPL | 2018-09-18 |
| 55503 | SUPPL | 2018-09-18 |
| 55502 | SUPPL | 2018-09-18 |
| 55498 | SUPPL | 2018-09-18 |
| 55497 | SUPPL | 2018-09-18 |
| 55496 | SUPPL | 2018-09-18 |
| 36600 | SUPPL | 2009-04-03 |
| 4947 | SUPPL | 2009-04-01 |
| 21579 | ORIG | 2004-06-29 |
| 15125 | ORIG | 2002-05-31 |
| 4946 | ORIG | 2002-05-31 |